Our Doctor

Dr Lim Zi Yi

Dr Lim Zi Yi is the Medical Director of CFCH and a Senior Consultant in Haematology.

He has more than 2 decades of experience as a haematologist having worked at top haematology centres in both London and Singapore.

He has a specialist interest in Haemato-oncology and Haematopoietic Stem Cell Transplantation. He is experienced in the treating of patients with haematological diseases including acute leukaemia, myelodysplastic syndromes, lymphoma, myeloma and aplastic anaemia. In addition, he has wide experience in the management of general haematological conditions (such as clotting disorders, anaemia, bleeding disorders). 

He received his medical degree from the University of Edinburgh, UK and subsequently underwent specialist training in haemato-oncology at Kings College Hospital, London. He did research as a Clinical Lecturer in Haematology at King College London for 2 years on transplant immunology before returning to full time clinical work. During his tenure at King College Hospital, he helped to develop it into one of the largest allogeneic haematopoietic stem cell transplant centres in Europe. During his time in London, he published more than 40 papers and presented more than 100 abstracts at international conferences. In 2007, he was awarded the prestigious Tito Bastianello Award for Best Young Investigator, at the 9th International Symposium on Myelodysplastic Syndromes, in Italy. He has also been the principal author on several key highly cited papers in the field of myelodysplastic syndromes and allogeneic haematopoeitic stem cell transplantation.

Dr Lim returned to Singapore in 2011 where he has led the development of several haematological services in the public and private sector. He was awarded the NUHS Clinician Scientist Program Award in 2012. He is presently the Medical Director of the Centre for Clinical Haematology, as well as a Visiting Consultant at the National University Cancer Institute, Singapore. Dr Lim continues to be active in medical research and clinical trials and is passionate about the development of new treatment strategies for patients with complex haematological disorders. He is presently working on introducing new innovative therapies such as CAR-T cell therapies and other cellular therapies into Singapore.

Dr Lim has been the President of the Singapore Bone Marrow Programme since 2013. The Charity runs the bone marrow registry for Singapore, and Dr Lim has been passionate about raising awareness of blood disorders and working to increase funding and support for patients and relatives affected by the disorder.

Dr Lim also serves on several committees advising on blood cancers, including the MOH Bone Marrow/Hematopoietic Stem Cell Transplant Working Committee, the  MOH COVID-19 Transplantation Services Advisory Committee as well as the MOH Drug Advisory Committee. He is also part of the Medical Advisory Board and Chair of the Blood Transfusion Services Committee for both Mount Elizabeth Novena Hospital and Mount Alvernia Hospital.

Dr Lim believes in approaching patient care in a holistic manner. He works closely with patients and their families to map out treatment options, and his CFCH team will work to support patients through all phases of their haematology journey.

Dr Lim is fluent in English and Chinese.

Qualifications

  • MBChB, University of Edinburgh
  • Fellow of the Royal College of Pathologists, UK
  • Fellow of the Royal College of Physicians (Edinburgh), UK
  • Tito Bastianello Award for Best Young Investigator, 9th International Symposium on Myelodysplastic Syndromes, Italy, 2007
  • Awarded the NUHS Clinician Scientist Program Award, 2012
    .

Background

  • Worked at King’s College Hospital, London for almost 10 years
  • Experienced in various forms of allogeneic haematopoietic stem cell transplantation and has personally overseen the management of more than 350 bone marrow transplants since 2008
  • Published more than 50 peer-reviewed papers on myeloid cancers and transplantation, many in high-impact journals such as Journal of Clinical Oncology, Blood, Leukemia and Haematologica
  • Lead for adult leukaemia service at NUHS (2011-2013)
  • Lead for adult haematopoietic stem cell transplant service at Parkway Cancer Centre (2013-2019)
  • President of the Bone Marrow Donor Programme (BMDP) Singapore
  • Co-Founder and CEO of the cellular therapy manufacturing start-up CellVec Pte Ltd
  • Formed the Centre for Clinical Haematology 2019

Media Highlights

Publications

Dr Lim is passionate about research and has published extensively throughout his career. To date, he has more than 50 publications in high impact peer-reviewed journals. 

 

 

 

Our Doctor

Dr Lim Zi Yi

Dr Lim Zi Yi is the Medical Director of CFCH and a Senior Consultant in Haematology.

He has more than 2 decades of experience as a haematologist having worked at top haematology centres in both London and Singapore.

He has a specialist interest in Haemato-oncology and Haematopoietic Stem Cell Transplantation. He is experienced in the treating of patients with haematological diseases including acute leukaemia, myelodysplastic syndromes, lymphoma, myeloma and aplastic anaemia. In addition, he has wide experience in the management of general haematological conditions (such as clotting disorders, anaemia, bleeding disorders). 

He received his medical degree from the University of Edinburgh, UK and subsequently underwent specialist training in haemato-oncology at Kings College Hospital, London. He did research as a Clinical Lecturer in Haematology at King College London for 2 years on transplant immunology before returning to full time clinical work. During his tenure at King College Hospital, he helped to develop it into one of the largest allogeneic haematopoietic stem cell transplant centres in Europe. During his time in London, he published more than 40 papers and presented more than 100 abstracts at international conferences. In 2007, he was awarded the prestigious Tito Bastianello Award for Best Young Investigator, at the 9th International Symposium on Myelodysplastic Syndromes, in Italy. He has also been the principal author on several key highly cited papers in the field of myelodysplastic syndromes and allogeneic haematopoeitic stem cell transplantation.

Dr Lim returned to Singapore in 2011 where he has led the development of several haematological services in the public and private sector. He was awarded the NUHS Clinician Scientist Program Award in 2012. He is presently the Medical Director of the Centre for Clinical Haematology, as well as a Visiting Consultant at the National University Cancer Institute, Singapore. Dr Lim continues to be active in medical research and clinical trials and is passionate about the development of new treatment strategies for patients with complex haematological disorders. He is presently working on introducing new innovative therapies such as CAR-T cell therapies and other cellular therapies into Singapore.

Dr Lim has been the President of the Singapore Bone Marrow Programme since 2013. The Charity runs the bone marrow registry for Singapore, and Dr Lim has been passionate about raising awareness of blood disorders and working to increase funding and support for patients and relatives affected by the disorder.

Dr Lim also serves on several committees advising on blood cancers, including the MOH Bone Marrow/Hematopoietic Stem Cell Transplant Working Committee, the  MOH COVID-19 Transplantation Services Advisory Committee as well as the MOH Drug Advisory Committee. He is also part of the Medical Advisory Board and Chair of the Blood Transfusion Services Committee for both Mount Elizabeth Novena Hospital and Mount Alvernia Hospital.

Dr Lim believes in approaching patient care in a holistic manner. He works closely with patients and their families to map out treatment options, and his CFCH team will work to support patients through all phases of their haematology journey.

Dr Lim is fluent in English and Chinese.

Qualifications

  • MBChB, University of Edinburgh
  • Fellow of the Royal College of Pathologists, UK
  • Fellow of the Royal College of Physicians (Edinburgh), UK
  • Tito Bastianello Award for Best Young Investigator, 9th International Symposium on Myelodysplastic Syndromes, Italy, 2007
  • Awarded the NUHS Clinician Scientist Program Award, 2012
    .

Background

  • Worked at King’s College Hospital, London for almost 10 years
  • Experienced in various forms of allogeneic haematopoietic stem cell transplantation and has personally overseen the management of more than 350 bone marrow transplants since 2008
  • Published more than 50 peer-reviewed papers on myeloid cancers and transplantation, many in high-impact journals such as Journal of Clinical Oncology, Blood, Leukemia and Haematologica
  • Lead for adult leukaemia service at NUHS (2011-2013)
  • Lead for adult haematopoietic stem cell transplant service at Parkway Cancer Centre (2013-2019)
  • President of the Bone Marrow Donor Programme (BMDP) Singapore
  • Co-Founder and CEO of the cellular therapy manufacturing start-up CellVec Pte Ltd
  • Formed the Centre for Clinical Haematology 2019

Media Highlights

Publications

Dr Lim is passionate about research and has published extensively throughout his career. To date, he has more than 50 publications in high impact peer-reviewed journals. 

Locations

Contact

WhatsApp : +65 6256 8836
Email : contact@cfch.com.sg
.

Consultation Hours

Monday to Friday : 8.30am – 5.30pm
Saturday : 8.30am – 12.30pm
Closed on Sunday & Public Holidays

Find us on Facebook

Drop a Line

If you have any questions about your condition or would like to make an appointment, simply fill up the form and we'll contact you as soon as we can

© Centre for Clinical Haematology | 2020

Locations

Contact

WhatsApp : +65 6256 8836
Email : contact@cfch.com.sg

.

Consultation Hours

Monday to Friday : 8.30am – 5.30pm
Saturday : 8.30am – 12.30pm
Closed on Sunday & Public Holidays

 

Find us On Facebook

Drop a Line

If you have any questions about your condition or would like to make an appointment, simply fill up the form and we'll contact you as soon as we can

© Centre for Clinical Haematology | 2020